Invention Grant
- Patent Title: Optimized nucleic acid antibody constructs encoding anti-respiratory syncytial virus (RSV) antibodies
-
Application No.: US16611943Application Date: 2018-05-10
-
Publication No.: US12054537B2Publication Date: 2024-08-06
- Inventor: David Weiner , Ghiabe Guibinga , Neil Cooch , Charles Reed
- Applicant: The Wistar Institute of Anatomy and Biology , INOVIO PHARMACEUTICALS, INC.
- Applicant Address: US PA Philadelphia
- Assignee: The Wistar Institute of Anatomy and Biology,Inovio Pharmaceuticals, Inc.
- Current Assignee: The Wistar Institute of Anatomy and Biology,Inovio Pharmaceuticals, Inc.
- Current Assignee Address: US PA Philadelphia; US PA Plymouth Meeting
- Agency: Riverside Law LLP
- International Application: PCT/US2018/032023 2018.05.10
- International Announcement: WO2018/209055A 2018.11.15
- Date entered country: 2019-11-08
- Main IPC: C07K16/10
- IPC: C07K16/10 ; C07K16/00 ; A61K39/00 ; A61K48/00 ; C12N15/10 ; G16B15/20 ; G16B30/10
Abstract:
Disclosed herein are compositions comprising structurally modified DNA encoded antibodies (DMAbs), methods of structurally modifying DMAbs, and methods of using structurally modified DMAbs.
Public/Granted literature
- US20210188947A1 OPTIMIZED NUCLEIC ACID ANTIBODY CONSTRUCTS Public/Granted day:2021-06-24
Information query
